xCures and BioSpark partner to boost Real World Oncology Data offerings

Mar. 3, 2022

New partnership allows for a 40,000+ patient dataset to unlock new insights into cancer treatments and outcomes.

OAKLAND, CA, UNITED STATES, March 3, 2022 /EINPresswire.com/ -- xCures, Inc. and BioSpark, Inc. are proud to announce their strategic partnership to harmonize and commercialize a joint oncology Real World Data (RWD) offering. The partnership unlocks new insights into the treatment and outcomes of cancer patients through a novel dataset spanning 40,000+ cancer patients. The data results from the combined structuring of published case reports and comprehensive, cross-provider, Electronic Health Reports (EHRs) collected through XCELSIOR (NCT03793088).


RWD is necessary to provide direct insight and clinical decision support to patients ... Read more